|
GOLGB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.202200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.342140E-02 |
| Normal-vs-Stage2 |
2.357000E-01 |
| Normal-vs-Stage3 |
2.022900E-03 |
| Normal-vs-Stage4 |
9.517900E-02 |
| Stage1-vs-Stage2 |
8.873400E-01 |
| Stage1-vs-Stage3 |
1.306040E-01 |
| Stage1-vs-Stage4 |
1.197770E-01 |
| Stage2-vs-Stage3 |
3.692800E-01 |
| Stage2-vs-Stage4 |
3.361000E-01 |
| Stage3-vs-Stage4 |
6.692200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.036500E-02 |
| Normal-vs-AfricanAmerican |
4.559600E-02 |
| Normal-vs-Asian |
4.960200E-03 |
| Caucasian-vs-AfricanAmerican |
6.367600E-01 |
| Caucasian-vs-Asian |
3.452600E-01 |
| AfricanAmerican-vs-Asian |
4.037600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.561700E-03 |
| Normal-vs-Female |
8.992400E-01 |
| Male-vs-Female |
1.639650E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.305800E-02 |
| Normal-vs-Extreme_Weight |
1.430440E-04 |
| Normal-vs-Obese |
2.072000E-01 |
| Normal-vs-Extreme_Obese |
5.699000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.886800E-01 |
| Normal_Weight-vs-Obese |
3.871400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.428000E-01 |
| Extreme_Weight-vs-Obese |
3.183600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.511400E-01 |
| Obese-vs-Extreme_Obese |
8.931600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.498200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.188800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.164500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.225600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.521400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.013200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.055800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.682100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.398300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.226400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.049600E-01 |
| Normal-VS-Type2 PRCC |
2.05610000003631E-06 |
| Normal-VS-KIRP CIMP |
5.575200E-01 |
| Normal-VS-Unclassified PRCC |
8.797200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.54150000000386E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.967400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.158000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.212600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.540450E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.548400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.35319999999773E-05 |
| Normal-vs-N1 |
9.103500E-02 |
| Normal-vs-N2 |
9.979600E-01 |
| N0-vs-N1 |
3.557800E-01 |
| N0-vs-N2 |
6.100800E-01 |
| N1-vs-N2 |
7.358600E-01 |
|
|
